249 related articles for article (PubMed ID: 2997100)
1. The in-vitro activity of a novel penem FCE 22101 compared to other beta-lactam antibiotics.
Neu HC; Chin NX; Labthavikul P
J Antimicrob Chemother; 1985 Sep; 16(3):305-13. PubMed ID: 2997100
[TBL] [Abstract][Full Text] [Related]
2. In-vitro activity of a new penem FCE 22101.
Hoban DJ
J Antimicrob Chemother; 1989 Mar; 23 Suppl C():53-7. PubMed ID: 2786518
[TBL] [Abstract][Full Text] [Related]
3. Comparison of in vitro activity of FCE 22101, a new penem, with those of other beta-lactam antibiotics.
Wise R; Andrews JM; Danks G
Antimicrob Agents Chemother; 1983 Dec; 24(6):909-14. PubMed ID: 6607032
[TBL] [Abstract][Full Text] [Related]
4. In-vitro activity of FCE 22101 against respiratory tract pathogens with reference to production of beta-lactamases.
Dornbusch K; Kronvall G; Göransson E; Mörtsell E
J Antimicrob Chemother; 1989 Mar; 23 Suppl C():31-41. PubMed ID: 2786517
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of imipenem--a review.
Braveny I
Eur J Clin Microbiol; 1984 Oct; 3(5):456-62. PubMed ID: 6389125
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem.
Neu HC; Chin NX; Saha G; Labthavikul P
Antimicrob Agents Chemother; 1986 Dec; 30(6):828-34. PubMed ID: 3545068
[TBL] [Abstract][Full Text] [Related]
7. The activity of BMY 28142 a new broad spectrum beta-lactamase stable cephalosporin.
Neu HC; Chin NX; Jules K; Labthavikul P
J Antimicrob Chemother; 1986 Apr; 17(4):441-52. PubMed ID: 3486862
[TBL] [Abstract][Full Text] [Related]
8. In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase I.
Edwards JR; Turner PJ; Wannop C; Withnell ES; Grindey AJ; Nairn K
Antimicrob Agents Chemother; 1989 Feb; 33(2):215-22. PubMed ID: 2655530
[TBL] [Abstract][Full Text] [Related]
9. Comparative in-vitro activity of the penem FCE 22101 against recent European blood culture isolates.
Dornbusch K; Kronvall G; Göransson E; Mörtsell E
J Antimicrob Chemother; 1989 Mar; 23 Suppl C():43-52. PubMed ID: 2732143
[TBL] [Abstract][Full Text] [Related]
10. In-vitro evaluation of Sch 34343: antimicrobial activity, beta-lactamase stability and inhibition.
Jones RN; Barry AL; Fuchs PC; Thornsberry C
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():99-109. PubMed ID: 3875606
[TBL] [Abstract][Full Text] [Related]
11. Comparative in-vitro activity of Sch 34343, imipenem, cefpirome and cefotaxime.
Bauernfeind A
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():155-64. PubMed ID: 3897170
[TBL] [Abstract][Full Text] [Related]
12. The in-vitro activity of faropenem, a novel oral penem.
Woodcock JM; Andrews JM; Brenwald NP; Ashby JP; Wise R
J Antimicrob Chemother; 1997 Jan; 39(1):35-43. PubMed ID: 9044026
[TBL] [Abstract][Full Text] [Related]
13. Sch 34343: in-vitro antibacterial activity and susceptibility to beta-lactamases.
Shannon K; King A; Phillips I
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():15-23. PubMed ID: 3897169
[TBL] [Abstract][Full Text] [Related]
14. In-vitro activity of FCE 22101 and synergy studies with other antimicrobial agents.
Chin NX; Neu HC
J Antimicrob Chemother; 1989 Mar; 23 Suppl C():95-101. PubMed ID: 2786520
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
Krause R; Mittermayer H; Feierl G; Allerberger F; Wendelin I; Hirschl A; Reisinger EC
Wien Klin Wochenschr; 1999 Jul; 111(14):549-54. PubMed ID: 10467641
[TBL] [Abstract][Full Text] [Related]
16. In-vitro activity of the penem, FCE 22101, and tentative interpretive criteria for disc susceptibility tests.
Barry AL; Jones RN; Thornsberry C
J Antimicrob Chemother; 1989 Mar; 23 Suppl C():17-30. PubMed ID: 2732139
[TBL] [Abstract][Full Text] [Related]
17. Comparative inhibitory and bactericidal activities of FCE 22101 against gram-positive cocci and anaerobes in vitro.
Maskell JP; Tang T; Asad S; Williams JD
J Antimicrob Chemother; 1989 Mar; 23 Suppl C():65-74. PubMed ID: 2732145
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the in-vitro antibacterial activity of Sch 34343.
Adam C; Naples L; Weiss W; Sabatelli F; Hare R; Loebenberg D; Miller GH
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():39-56. PubMed ID: 3875604
[TBL] [Abstract][Full Text] [Related]
19. Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
Phillips I; Warren C; Shannon K; King A; Hanslo D
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():23-31. PubMed ID: 19802967
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of CGP 31608, a new penem.
Wise R; Andrews JM; Piddock LJ
Antimicrob Agents Chemother; 1987 Feb; 31(2):267-73. PubMed ID: 3105451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
